ACE Inhibitor-Induced Angioedema: a Review-Reference-Cited by-同舟云学术

ACE Inhibitor-Induced Angioedema: a Review

Published:2018-06-08 Issue:7 Volume:20 Page:
ISSN:1522-6417
Container-title:Current Hypertension Reports
language:en
Short-container-title:Curr Hypertens Rep

Author:

Kostis William J.,Shetty Mrinali,Chowdhury Yuvraj Singh,Kostis John B.

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/article/10.1007/s11906-018-0859-x/fulltext.html

Reference59 articles.

1. Osler W. Hereditary angio-neurotic oedema. Am J Med Sci. 1888;95:362–7.

2. Hedner T, Samuelsson O, Lunde H, Lindholm L, Andrén L, Wiholm BE. Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors. BMJ. 1992;304:941–6.

3. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med. 2002;347:621–2.

4. Lin RY, Cannon AG, Teitel AD. Pattern of hospitalizations for angioedema in New York between 1990 and 2003. Ann Allergy Asthma Immunol. 2005;95:159–66.

5. IQVIA Institute for Human Data Science. Medicines use and spending in the U.S. [Internet]. 2017 May. Available from: https://www.iqvia.com/institute/reports/medicines-use-and-spending-in-the-us-a-review-of-2016 .

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Fresh Frozen Plasma in a Dramatic Case of ACE-Inhibitor Associated Angioedema;Eurasian Journal of Critical Care;2024-09-05

2. Epinephrine, Pregabalin, and Crizotinib as Three Medicines with Polish Implications over Three Last Centuries and in View of Three Different Drug Discovery Approaches;Biomedicines;2024-09-04

3. Sex-specific considerations in cardiovascular drug therapy;Canadian Journal of Physiology and Pharmacology;2024-09-01

4. A practical guide to recognize allergic and immunologic skin diseases: diagnosis at first sight;Exploration of Asthma & Allergy;2024-08-26

5. A pharmacovigilance study assessing risk of angioedema with angiotensin receptor blockers using the US FDA Adverse Event Reporting System;Expert Opinion on Drug Safety;2024-08-19